MK-6158

N/A

Report date: 2024/07/18 17:33:13

NME

Base Information

Drug NameMK-6158

Drug Alias NameMK-6158

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionSoluble guanylate cyclase stimulants

TargetsSoluble guanylate cyclase

Therapy Area/IndicationsPulmonary Arterial Hypertension

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesMerck & Co Inc

China Registration ClassN/A

Active CompaniesMerck & Co Inc

Inactive CompaniesN/A

Active IndicationsPulmonary Arterial Hypertension

Inactive IndicationsN/A

ATC CodeN/A